National

Canada grants patent waiver for Rwanda Aids drug

GENEVA – Canada has authorised a company to make a generic version of a patented Aids therapy drug for export to Rwanda, in the first case of a patent waiver under World Trade Organisation (WTO) rules.
no image
Times Reporter